GABELLI & Co INVESTMENT ADVISERS INC. Invests $4,359,000 in Vascular Solutions, Inc. (VASC)

GABELLI & Co INVESTMENT ADVISERS INC. bought a new position in Vascular Solutions, Inc. (NASDAQ:VASC) during the fourth quarter, Holdings Channel reports. The fund bought 77,695 shares of the medical device company’s stock, valued at approximately $4,359,000. GABELLI & Co INVESTMENT ADVISERS INC. owned about 0.44% of Vascular Solutions at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the company. Texas Permanent School Fund boosted its stake in shares of Vascular Solutions by 0.3% in the third quarter. Texas Permanent School Fund now owns 13,325 shares of the medical device company’s stock worth $643,000 after buying an additional 43 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in shares of Vascular Solutions by 1.6% in the third quarter. Municipal Employees Retirement System of Michigan now owns 3,850 shares of the medical device company’s stock worth $186,000 after buying an additional 60 shares during the last quarter. Aperio Group LLC boosted its stake in shares of Vascular Solutions by 2.9% in the third quarter. Aperio Group LLC now owns 9,328 shares of the medical device company’s stock worth $450,000 after buying an additional 260 shares during the last quarter. New York State Teachers Retirement System boosted its stake in shares of Vascular Solutions by 3.1% in the second quarter. New York State Teachers Retirement System now owns 9,899 shares of the medical device company’s stock worth $412,000 after buying an additional 300 shares during the last quarter. Finally, Great West Life Assurance Co. Can boosted its stake in shares of Vascular Solutions by 3.2% in the third quarter. Great West Life Assurance Co. Can now owns 23,110 shares of the medical device company’s stock worth $1,114,000 after buying an additional 714 shares during the last quarter. Institutional investors and hedge funds own 80.18% of the company’s stock.

Institutional Ownership by Quarter for Vascular Solutions (NASDAQ:VASC)

Vascular Solutions, Inc. (NASDAQ:VASC) traded down 0.09% during trading on Monday, hitting $55.95. The stock had a trading volume of 114,155 shares. Vascular Solutions, Inc. has a 52 week low of $24.53 and a 52 week high of $57.15. The company’s 50-day moving average is $55.87 and its 200 day moving average is $51.01. The firm has a market cap of $980.97 million, a PE ratio of 81.32 and a beta of 0.98.

“GABELLI & Co INVESTMENT ADVISERS INC. Invests $4,359,000 in Vascular Solutions, Inc. (VASC)” was reported by sleekmoney and is owned by of sleekmoney. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at http://sleekmoney.com/gabelli-co-investment-advisers-inc-invests-4359000-in-vascular-solutions-inc-vasc/1659216.html.

A number of equities analysts have weighed in on the company. Canaccord Genuity cut Vascular Solutions from a “buy” rating to a “hold” rating in a report on Monday, December 5th. Zacks Investment Research upgraded Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a report on Thursday, October 27th. Needham & Company LLC cut Vascular Solutions from a “buy” rating to a “hold” rating in a report on Friday, December 2nd. Feltl & Co. cut Vascular Solutions from a “buy” rating to a “hold” rating in a report on Friday, December 2nd. Finally, Piper Jaffray Companies cut Vascular Solutions from an “overweight” rating to a “neutral” rating in a report on Monday, December 5th. Six investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $51.80.

In other Vascular Solutions news, VP Chad Kugler sold 1,849 shares of Vascular Solutions stock in a transaction on Thursday, December 22nd. The stock was sold at an average price of $55.70, for a total value of $102,989.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 6.90% of the stock is owned by insiders.

About Vascular Solutions

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

5 Day Chart for NASDAQ:VASC

Want to see what other hedge funds are holding VASC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vascular Solutions, Inc. (NASDAQ:VASC).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/gabelli-co-investment-advisers-inc-invests-4359000-in-vascular-solutions-inc-vasc/1659216.html

Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *